MedPath

Vitamin D3

Generic Name
Vitamin D3
Brand Names
Adrovance, Animi-3 With Vitamin D, Citranatal B-calm Kit, Citranatal Harmony, Fosamax Plus D, Fosavance, Infuvite, Infuvite Pediatric, Mvc-fluoride, Natafort, Pregvit, Vidextra
Drug Type
Small Molecule
Chemical Formula
C27H44O
CAS Number
67-97-0
Unique Ingredient Identifier
1C6V77QF41
Background

Vitamin D, in general, is a secosteroid generated in the skin when 7-dehydrocholesterol located there interacts with ultraviolet irradiation - like that commonly found in sunlight . Both the endogenous form of vitamin D (that results from 7-dehydrocholesterol transformation), vitamin D3 (cholecalciferol), and the plant-derived form, vitamin D2 (ergocalciferol), are considered the main forms of vitamin d and are found in various types of food for daily intake . Structurally, ergocalciferol differs from cholecalciferol in that it possesses a double bond between C22 and C23 and has an additional methyl group at C24 . Finally, ergocalciferol is pharmacologically less potent than cholecalciferol, which makes vitamin D3 the preferred agent for medical use .

Appropriate levels of vitamin D must be upheld in the body in order to maintain calcium and phosphorus levels in a healthy physiologic range to sustain a variety of metabolic functions, transcription regulation, and bone metabolism . However, studies are also ongoing to determine whether or not cholecalciferol may also play certain roles in cancer, autoimmune disorders, cardiovascular disease, and other medical conditions that may be associated with vitamin D deficiency .

Indication

Cholecalciferol use is indicated for the treatment of specific medical conditions like refractory rickets (or vitamin D resistant rickets), hypoparathyroidism, and familial hypophosphatemia .

Concurrently, as one of the most commonly utilized forms of vitamin D, cholecalciferol is also very frequently used as a supplement in individuals to maintain sufficient vitamin d levels in the body or to treat vitamin D deficiency, as well as various medical conditions that can be associated directly or indirectly with vitamin d insufficiency like osteoporosis and chronic kidney disease, among others .

Associated Conditions
Bone Fractures, Calcium and Vitamin D Deficiencies, Deficiency of Vitamin D3, Deficiency, Vitamin A, Deficiency, Vitamin D, Hip Fracture, Hypoparathyroidism, Hypophosphatemia, Familial, Menopause, Osteomalacia, Osteoporosis, Postmenopausal Osteoporosis, Vertebral Fractures, Vitamin D Resistant Rickets, Vitamin Deficiency, Severe Bone Resorption, Spine fracture
Associated Therapies
Calcium supplementation, Nutritional supplementation, Vitamin D Supplementation, Vitamin supplementation

Study of Vitamin D for Premenopausal Women at High Risk for Breast Cancer

Phase 1
Completed
Conditions
Breast Cancer
Interventions
First Posted Date
2009-09-14
Last Posted Date
2017-09-29
Lead Sponsor
Katherine D. Crew
Target Recruit Count
20
Registration Number
NCT00976339
Locations
🇺🇸

Columbia University Medical Center Herbert Irving Cancer Center, New York, New York, United States

Vitamin D and Chronic Renal Insufficiency

Phase 3
Completed
Conditions
Vitamin D Deficiency
Chronic Renal Insufficiency
Interventions
First Posted Date
2009-08-31
Last Posted Date
2011-01-26
Lead Sponsor
Odense University Hospital
Target Recruit Count
56
Registration Number
NCT00968877

Vitamin D, Blood Pressure, Lipids, Infection and Depression

Phase 3
Completed
Conditions
Hypovitaminosis D
Interventions
First Posted Date
2009-08-17
Last Posted Date
2012-09-05
Lead Sponsor
University of Tromso
Target Recruit Count
250
Registration Number
NCT00960232
Locations
🇳🇴

University of Tromsø, Tromsø, Norway

Vitamin D Supplementation in Veterans With Early-Stage Prostate Cancer

Phase 2
Completed
Conditions
Prostate Cancer
Interventions
Drug: Placebo daily for one year
Drug: vitamin D3
First Posted Date
2009-08-06
Last Posted Date
2017-10-09
Lead Sponsor
VA Office of Research and Development
Target Recruit Count
83
Registration Number
NCT00953225
Locations
🇺🇸

Ralph H. Johnson VA Medical Center, Charleston, SC, Charleston, South Carolina, United States

🇺🇸

Medical University of South Carolina, Charleston, South Carolina, United States

Effect of Vitamin D3 on Vascular Function

Not Applicable
Completed
Conditions
Vitamin D Deficiency
Interventions
Drug: Placebo
Drug: Vitamin D
First Posted Date
2009-07-29
Last Posted Date
2018-07-17
Lead Sponsor
Charles Drew University of Medicine and Science
Target Recruit Count
130
Registration Number
NCT00948298

Vitamin D and Arteriovenous Fistulae

Not Applicable
Completed
Conditions
End-stage Renal Disease
Interventions
Drug: Placebo
Drug: Vitamin D3
First Posted Date
2009-06-03
Last Posted Date
2014-07-02
Lead Sponsor
Emory University
Target Recruit Count
52
Registration Number
NCT00912782
Locations
🇺🇸

Emory University, Atlanta, Georgia, United States

Ph I/II of Vitamin D on Bone Mineral Density & Markers of Bone Resorption

Phase 1
Terminated
Conditions
Breast Cancer
Bone Diseases
Interventions
First Posted Date
2009-05-19
Last Posted Date
2017-02-14
Lead Sponsor
Mark Pegram
Target Recruit Count
8
Registration Number
NCT00904423
Locations
🇺🇸

Stanford University School of Medicine, Stanford, California, United States

Impact of Vitamin D Supplementation on Lactation Associated Bone Loss

Not Applicable
Completed
Conditions
Osteoporosis
Interventions
Dietary Supplement: Multivitamin
Drug: Vitamin D3
First Posted Date
2009-05-18
Last Posted Date
2014-08-18
Lead Sponsor
Leigh Eck, MD
Target Recruit Count
22
Registration Number
NCT00903344
Locations
🇺🇸

University of Kansas Medical Center, Kansas City, Missouri, United States

Vitamin D in Minorities With Prediabetes

Not Applicable
Completed
Conditions
Pre-diabetes
Interventions
Drug: placebo
Drug: vitamin D
First Posted Date
2009-04-07
Last Posted Date
2013-06-14
Lead Sponsor
Charles Drew University of Medicine and Science
Target Recruit Count
117
Registration Number
NCT00876928
Locations
🇺🇸

Charles Drew University, Los Angeles, California, United States

Vitamin D in Postmenopausal Women at High Risk for Breast Cancer

Phase 2
Completed
Conditions
Breast Cancer
Interventions
Drug: Cholecalciferol
Drug: Placebo capsule
First Posted Date
2009-03-11
Last Posted Date
2017-09-27
Lead Sponsor
Columbia University
Target Recruit Count
20
Registration Number
NCT00859651
Locations
🇺🇸

Columbia University, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath